ArticleBMC nephrology2025
Peritoneal dialysis related peritonitis caused by commensal neisseria species: a retrospective case series.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCommensal Neisseria species are increasingly recognized as invasive pathogens. Neisseria peritoneal dialysis (PD) related peritonitis is extremely rare, and its clinical course remains unclear. This study aimed to provide an overview of the clinical characteristics and coutcomes of Neisseria peritonitis.
methodsThis single-center study retrospectively reviewed all Neisseria peritonitis episodes diagnosed from 1 January 2014 to 31 March 2024. Demographics, biochemical data and clinical outcomes were recorded.
resultsDuring this period, 433 episodes of peritonitis were recorded, 13 (3.0%) of which were caused by Neisseria species. All patients had hypoproteinemia, and 63.64% of them had diabetes. More than half of the peritonitis cases occurred in winter (7/13). N. sicca was the most common species identified. 3 episodes of peritonitis were related to contamination during exchange procedures. 8 patients achieved primary response using amikacin or ceftizoxime, 2 patients were cured by switching amikacin to ceftriaxone and 1 patient had the catheter removed due to three episodes of Neisseria peritonitis within six months.
conclusionsNeisseria species can cause PD related peritonitis, and contamination during PD exchange is a plausible transmission route. Our study suggests that empirical therapy with amikacin or third-generation cephalosporins may achieve complete cure in most cases. While the overall outcome of Neisseria peritonitis is generally favorable, biofilm formation warrant special clinical attention due to potential treatment challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.